RxDoctor Payments DataLook up a doctor →

Bailey Stokes

Physician Assistant · Gulfport, MSNPI 1699441980

Payments from drug & device makers

$8,204in general payments, 2019–2025

Across 416 payments — averaging $19.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exelixis Inc.$1K
  • Novartis$970
  • Johnson & Johnson$574
  • Merck$544
  • Eisai Inc.$460
  • AstraZeneca$427
  • plus $4K from 48 others

What the payments were for

  • Food & beverage$7,85296%
  • Education$3514%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,204 in reported general payments places this provider in the 95th percentile of 278 physician assistant providers in Mississippi.

See all physician assistant providers in Mississippi

Medicare billing

Part B allowed, 2024
$915
Medicare patients
11
Services billed
12

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban22$18,826
XareltoRivaroxaban26$18,695
Letrozole111$1,844
Fentanyl14$1,388
Imatinib Mesylate12$1,388
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen83$1,247
Ondansetron Hcl68$985
Gabapentin96$984
Potassium Chloride47$766
Buspirone Hcl109$764
Doxycycline Hyclate49$687
Hydrocortisone17$663
Midodrine Hcl12$662
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen23$575
Levothyroxine Sodium53$507

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$115$18,82622 claims
Johnson & JohnsonXarelto$574$18,69526 claims
Lilly USA, LLCOlanzapine$395$43932 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 278 physician assistant providers in Mississippi.

Other physician assistant in Gulfport

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →